Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMSMQE7)

Drug Name
TMP269 Drug Info
Synonyms TMFO1; compound 1 [PMID: 23524983]; TMP-269; TMP 269
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
53344908
TTD Drug ID
DMSMQE7

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Histone deacetylase 9 (HDAC9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID29671355-Compound-62 DMWRS34 N. A. N. A. Patented [2]
PMID29671355-Compound-43 DMVPMWJ N. A. N. A. Patented [2]
PMID29671355-Compound-25 DMPV0KZ N. A. N. A. Patented [2]
PMID29671355-Compound-21 DMPJN0M N. A. N. A. Patented [2]
PMID29671355-Compound-31 DM3H78D N. A. N. A. Patented [2]
PMID29671355-Compound-45a DM5LYKR N. A. N. A. Patented [2]
PMID29671355-Compound-73 DMCNF36 N. A. N. A. Patented [2]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Targeting Histone deacetylase 5 (HDAC5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID29671355-Compound-62 DMWRS34 N. A. N. A. Patented [2]
PMID29671355-Compound-43 DMVPMWJ N. A. N. A. Patented [2]
PMID29671355-Compound-25 DMPV0KZ N. A. N. A. Patented [2]
PMID29671355-Compound-31 DM3H78D N. A. N. A. Patented [2]
PMID29671355-Compound-67 DM1RPL4 N. A. N. A. Patented [2]
PMID29671355-Compound-23 DMUBOEX N. A. N. A. Patented [2]
PMID29671355-Compound-45a DM5LYKR N. A. N. A. Patented [2]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Targeting Histone deacetylase 4 (HDAC4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID29671355-Compound-62 DMWRS34 N. A. N. A. Patented [2]
PMID29671355-Compound-43 DMVPMWJ N. A. N. A. Patented [2]
PMID29671355-Compound-25 DMPV0KZ N. A. N. A. Patented [2]
PMID29671355-Compound-21 DMPJN0M N. A. N. A. Patented [2]
PMID29671355-Compound-31 DM3H78D N. A. N. A. Patented [2]
PMID29671355-Compound-56 DM0VBMI N. A. N. A. Patented [2]
PMID29671355-Compound-67 DM1RPL4 N. A. N. A. Patented [2]
PMID29671355-Compound-23 DMUBOEX N. A. N. A. Patented [2]
PMID29671355-Compound-61 DMXH1G3 N. A. N. A. Patented [2]
PMID29671355-Compound-45a DM5LYKR N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Histone deacetylase 7 (HDAC7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID29671355-Compound-62 DMWRS34 N. A. N. A. Patented [2]
PMID29671355-Compound-43 DMVPMWJ N. A. N. A. Patented [2]
PMID29671355-Compound-25 DMPV0KZ N. A. N. A. Patented [2]
PMID29671355-Compound-21 DMPJN0M N. A. N. A. Patented [2]
PMID29671355-Compound-31 DM3H78D N. A. N. A. Patented [2]
PMID29671355-Compound-56 DM0VBMI N. A. N. A. Patented [2]
PMID29671355-Compound-67 DM1RPL4 N. A. N. A. Patented [2]
PMID29671355-Compound-45a DM5LYKR N. A. N. A. Patented [2]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase 4 (HDAC4) TTTQGH8 HDAC4_HUMAN Inhibitor [1]
Histone deacetylase 5 (HDAC5) TTUELN5 HDAC5_HUMAN Inhibitor [1]
Histone deacetylase 7 (HDAC7) TTMUEK1 HDAC7_HUMAN Inhibitor [1]
Histone deacetylase 9 (HDAC9) TT8M4E1 HDAC9_HUMAN Inhibitor [1]

References

1 Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group. Nat Chem Biol. 2013 May;9(5):319-25.
2 HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17.